Acadia Pharmaceuticals | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
ALKERMES USD 1.64B 156.24M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Cytokinetics USD 886.54M 69.51M 2025-06
Eisai JPY 763.15B 35.49B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Incyte USD 3.64B 411.91M 2025-06
J&J USD 71.55B 15.66B 2025-03
Moderna USD 6.17B 595M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Prothena USD 485.41M 49.57M 2024-12
PTC Therapeutics USD 2.27B 43.53M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Acadia Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.